RC-1291

· Helsinn Therapeutics (U.S.), Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RC-1291, covering 2013-09-02 to 2013-09-02. Get the full timeline:

Most recent: Clinical Trial Update: Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia [Phase 2]